Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000338316

Medchemexpress LLC SR-4835 | 2387704-62-1 | 99.7% | 100 MG
SDP

Supplier:  Medchemexpress LLC HY130250100MG

Encompass_Preferred

SR-4835 is a potent, highly selective, and ATP-competitive dual inhibitor of CDK12/CDK13. It acts synergistically with DNA-damaging chemotherapy and PARP inhibitors to induce cell death in triple-negative breast cancer (TNBC) cells.

  • Potent and highly selective ATP-competitive dual inhibitor of CDK12/CDK13
  • Acts synergistically with DNA-damaging chemotherapy
  • Induces cell death in triple-negative breast cancer (TNBC) cells
  • Inhibits CDK12/CDK13, suppressing expression of core DNA damage response proteins

Catalog No. 50-003-38316


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.